Allergan announced that it has halted sales of textured breast implants and tissue expanders in Europe due to expired CE Marks, and is initiating a withdrawal of all remaining supplies in those markets.
The company’s move to withdraw the products came after France’s regulatory authority, Agence Nationale de Sécurité du Médicament, requested a recall. The company said it disagreed with the need for a recall but agreed to comply.
Allergan said no immediate risk has been identified to women using the textured breast implants.
